Variant Ciz1 is a circulating biomarker for early-stage lung cancer
about
The Role of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA Replication and PathophysiologyLung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repositoryThe nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumA genotoxic stress-responsive miRNA, miR-574-3p, delays cell growth by suppressing the enhancer of rudimentary homolog gene in vitro.Current readings: blood-based biomarkers for lung cancer.Relationship between DNA replication and the nuclear matrix.CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.CIZ1 promoted the growth and migration of gallbladder cancer cells.Emerging Roles for Ciz1 in Cell Cycle Regulation and as a Driver of Tumorigenesis.Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules.A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma.Cardiomyocyte--specific expression of the nuclear matrix protein, CIZ1, stimulates production of mono-nucleated cells with an extended window of proliferation in the postnatal mouse heart.Ciz1 is a novel predictor of survival in human colon cancer.CIZ1, a p21Cip1/Waf1-interacting protein, functions as a tumor suppressor in vivo.CDKN1A-interacting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma.DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1).Discovery of Transcription Factors Novel to Mouse Cerebellar Granule Cell Development Through Laser-Capture Microdissection.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.CIZ1-F, an alternatively spliced variant of the DNA replication protein CIZ1 with distinct expression and localisation, is overrepresented in early stage common solid tumoursExamining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes
P2860
Q26767281-FE26D197-88DA-4268-B2F8-1356091A26FEQ28384727-7997A0A6-2E22-4716-B8FC-7A7C5F05BD3DQ33763595-22BD2BB0-12C6-4DA9-B7A1-F8D1BC923FE1Q35957217-E5A04DDC-C229-4D81-A405-342B1BA74DB8Q37645370-1F6E8A75-3BAE-426A-96A8-AF9ACD23E69DQ37672473-1F0FE4B4-073A-4D11-B1DA-EE8664CB94EEQ38058379-6EF215B9-AEDD-474F-82A2-95514DD42F2EQ38791675-54358CD8-5011-4568-AB20-EBB46222230CQ38937527-5E1EBDCE-8CA6-498D-993C-4D03007F75EFQ39063003-2A709E25-603C-4E3B-9CB6-EB425AF568A6Q39779374-CC22280C-BE64-4437-B85F-5C7E2429BFE4Q40955173-8F4E2389-B1AD-463C-A3CA-10E16993C3EBQ41811276-0C66FBC0-3C45-4B56-B1D0-6C4BA49B908FQ42326571-CA0341EF-4B66-4F40-9424-064B1C6ED885Q44585258-F19E3FD9-CAB5-45DF-9217-6E97307D579AQ45715060-EA72B1EA-6B52-4A17-B942-2C9E36B18A0EQ47171862-6A169FD7-9519-474A-AFD6-0CE3C1FAB40FQ47386934-384793D4-2FB6-4BB5-945E-A500DC4D67CFQ47635276-93F4D32A-EAC7-4D3A-BF2F-2277F7B4B6B8Q50146854-17605B87-77E5-4EA2-8DBD-3897F0570AD9Q51621075-FEA0438B-43B0-400D-9ECB-837E03BE63C2Q54962725-EA97B7B5-0EB5-4C77-9AFE-EC9FC2B10F0BQ57035088-2E065A5D-60D1-4A58-B795-444ADB3F7B14Q58782636-2C45563D-AC6C-4058-8B71-B717CAA49CB9
P2860
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@ast
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@en
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@nl
type
label
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@ast
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@en
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@nl
prefLabel
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@ast
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@en
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@nl
P2093
P2860
P50
P356
P1476
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
@en
P2093
Irene J Watson
Katherine M Roper
William N Rom
P2860
P304
P356
10.1073/PNAS.1210107109
P407
P577
2012-10-16T00:00:00Z